- Question ID
-
2023_6954
- Legal act
- Regulation (EU) No 575/2013 (CRR)
- Topic
- Transparency and Pillar 3
- Article
-
449a
- COM Delegated or Implementing Acts/RTS/ITS/GLs/Recommendations
- Regulation (EU) 2022/2453 - ITS on ESG disclosures
- Article/Paragraph
-
Template 1
- Type of submitter
-
Competent authority
- Subject matter
-
Template 1 – Equity instruments
- Question
-
The instructions state “Institutions shall disclose the gross carrying amount, referred to in Part 1 of Annex V to Implementing Regulation (EU) 2021/451, of those exposures towards non-financial corporates, including loans and advances, debt securities and equity instruments, classified in the accounting portfolios in the banking book in accordance with that Implementing Regulation, excluding financial assets held for trading or held for sale assets”.
In this case, should the definition of equity instruments also include investments in subsidiaries, joint ventures and associates, or should entities consider the definition of accounting portfolios of financial instruments provided by Annex V of FINREP, which specifically excludes investments in subsidiaries, joint ventures and associates?
- Background on the question
-
Instructions state “Institutions shall disclose the gross carrying amount, referred to in Part 1 of Annex V to Implementing Regulation (EU) 2021/451, of those exposures towards non-financial corporates, including loans and advances, debt securities and equity instruments, classified in the accounting portfolios in the banking book in accordance with that Implementing Regulation, excluding financial assets held for trading or held for sale assets”, however it is not clear which definition of "Equity instruments" should be considered.
- Submission date
- Final publishing date
-
- Final answer
-
The instructions provided in Annex XL of Regulation (EU) 2021/637 for Template 1 do not exclude the scope of investments in subsidiaries, joint ventures and associates within equity instruments. It defines the scope as “[...] exposures towards non-financial corporates, including […]”, but not limited to, “[…] loans and advances, debt securities and equity instruments, classified in the accounting portfolios in the banking book […]”. Therefore, investments in subsidiaries, joint ventures and associates should be included and considered when completing Template 1.
This is strengthened by the DPM table layout and data point categorisation updated on October 30, 2023 (EBA DPM for Reporting Framework 3.3) which defines the scope as “Accounting portfolio for financial assets other than trading or held for sale, including Investments in subsidiaries, joint ventures and associates”.
- Status
-
Final Q&A
- Answer prepared by
-
Answer prepared by the EBA.
Disclaimer
The Q&A refers to the provisions in force on the day of their publication. The EBA does not systematically review published Q&As following the amendment of legislative acts. Users of the Q&A tool should therefore check the date of publication of the Q&A and whether the provisions referred to in the answer remain the same.